Scarica l'app Stockscreener
12.21
4.36%
0.51
Dopo l'orario di chiusura:
12.60
0.39
+3.19%
Precedente Chiudi:
$11.70
Aprire:
$11.45
Volume 24 ore:
214.00K
Relative Volume:
0.48
Capitalizzazione di mercato:
$13.87M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+17.07%
1M Prestazione:
+2.78%
6M Prestazione:
-80.11%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$10.81
$12.70
Intervallo di 1 settimana:
$9.685
$17.15
Portata 52W:
$7.51
$121.80
Autonomix Medical Inc Stock (AMIX) Company Profile
Nome
Autonomix Medical Inc
Settore
Industria
Telefono
832-277-7816
Indirizzo
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - Yahoo Finance
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Autonomix announces preliminary results from trial on ablation technology - TipRanks
Autonomix Shares Soar 85% on Results From Pain-Management Study - MarketWatch
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday? - Benzinga
Autonomix (AMIX) Stock Soars On Positive Pain Management Trial Outcomes - Stocks Telegraph
Autonomix jumps after its treatment reduces pain during trial - XM
Autonomix reports breakthrough in pancreatic cancer pain - Investing.com India
Positive Preliminary Results Demonstrate Autonomix’s - GlobeNewswire
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - StockTitan
1,518,000 Common Stock of Autonomix Medical, Inc. are subject to a Lock-Up Agreement Ending on 27-OCT-2024. - Marketscreener.com
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th - GlobeNewswire
Autonomix Medical to conduct a reverse stock split - MSN
Autonomix Medical announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
Nerve ablation tech developer Autonomix to effect a reverse stock split - Mass Device
Autonomix Announces Reverse Stock Split - citybiz
Autonomix Medical announces 1-for-20 reverse stock split - Investing.com
Autonomix Medical ratifies new auditor, approves reverse stock split - Investing.com India
Autonomix Medical ratifies new auditor, approves reverse stock split By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewswire
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer - AccessWire
Autonomix Flat on Unveiling Corner Segment - Baystreet.ca
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - GlobeNewswire
Potential Price Increase for Vor Biopharma Inc (VOR) After Recent Insider Activity - Knox Daily
VOR’s Stock Market Adventure: -65.78% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.83, Down -7.78 - The Dwinnex
Stock hits 5% upper circuit after Motilal Oswal Mutual Fund bought 2.12% stake - Trade Brains
Motilal Oswal MF buys 2% in smallcap stock that is up 1,515% in 16 months - Business Standard
Autonomix Medical faces potential Nasdaq delisting - Investing.com
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum - GlobeNewswire
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Moove, Rappi edge closer to IPOs - LatinFinance
Ladenburg Thalmann Initiates Coverage of Autonomix Medical (AMIX) with Buy Recommendation - MSN
Autonomix rises after it reports reduction of pain in pancreatic cancer treatment - MSN
Autonomix reports pain relief in pancreatic cancer trial - Investing.com India
Autonomix reports pain relief in pancreatic cancer trial By Investing.com - Investing.com Canada
Autonomix reports pain reduction in pancreatic cancer patient treatment - TipRanks
Autonomix Medical Inc Azioni (AMIX) Dati Finanziari
Non sono disponibili dati finanziari per Autonomix Medical Inc (AMIX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):